2009
DOI: 10.1097/mjt.0b013e3180a5bd83
|View full text |Cite
|
Sign up to set email alerts
|

Bupropion-Associated QRS Prolongation Unresponsive to Sodium Bicarbonate Therapy

Abstract: We describe a case of bupropion-associated QRS prolongation that was unresponsive to intravenous bolus therapy of sodium bicarbonate. Bupropion may cause seizures and conduction delays similar to tricyclic antidepressants in the overdose setting by an unknown mechanism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 12 publications
(11 reference statements)
1
11
0
Order By: Relevance
“…In the present study, we have shown that bupropion is a weak I Kr blocker, with an estimated IC 50 on HERG tail currents of ∼34 μ m , a concentration well above the therapeutic range (0.05–0.1 mg/L:0.18–0.36 μ m ) [1], but nonetheless reachable in cases of overdosage (20 mg/L:72 μ m ) [21]. This is consistent with the fact that most cases of bupropion‐related QT interval prolongation have been reported in a context of drug overdosage [1,5,6,8–13,18]. We have also shown small and nonsignificant block of I Ks by bupropion 10 μ m , suggesting that bupropion‐related QT prolongation is, as for nearly all other QT‐prolonging drugs [32], mostly attributed to I Kr block.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…In the present study, we have shown that bupropion is a weak I Kr blocker, with an estimated IC 50 on HERG tail currents of ∼34 μ m , a concentration well above the therapeutic range (0.05–0.1 mg/L:0.18–0.36 μ m ) [1], but nonetheless reachable in cases of overdosage (20 mg/L:72 μ m ) [21]. This is consistent with the fact that most cases of bupropion‐related QT interval prolongation have been reported in a context of drug overdosage [1,5,6,8–13,18]. We have also shown small and nonsignificant block of I Ks by bupropion 10 μ m , suggesting that bupropion‐related QT prolongation is, as for nearly all other QT‐prolonging drugs [32], mostly attributed to I Kr block.…”
Section: Discussionsupporting
confidence: 88%
“…Indeed, sinus tachycardia is the most common cardiovascular side effect associated with bupropion, mostly during overdosage [1–17]. Nonetheless, a number of bupropion‐related QTc interval prolongation have been reported [1,5,6,8–13,18]. Again, most of these occurred during overdosage, and there has been no report of bupropion‐induced torsades de pointes.…”
Section: Introductionmentioning
confidence: 99%
“…QRS prolongation unresponsive to bicarbonate therapy has been previously reported with bupropion, another sodium channel blocker (10,11). In our report, as left bundle branch block was observed with a sinus rhythm of 88, it cannot be attributed to tachycardia-induced myocardial ischemia.…”
Section: Discussionmentioning
confidence: 57%
“…Interestingly, the QRS prolongation associated with bupropion does not appear to be responsive to sodium bicarbonate therapy as described in several case reports [72][73][74]. With regards to a possible mechanism for this finding, Caillier et al used patch clamp techniques to determine that bupropion did not significantly change sodium current amplitude or steady-state activation/inactivation.…”
Section: Antidepressantsmentioning
confidence: 99%
“…Case report [71] In vitro data (references) Bupropion Case reports [72][73][74] Guinea pig hearts, rat neonatal myocytes, rat atria, canine ventricular tissue, crayfish axons [75,76] Human embryonic kidney cells [75] Propranolol Canine study [77] …”
Section: Propoxyphenementioning
confidence: 99%